Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers

被引:0
作者
Peiyi Xia
Lan Zhang
Pan Li
Enjie Liu
Wencai Li
Jianying Zhang
Hui Li
Xiaoxing Su
Guozhong Jiang
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Pathology
[2] Zhengzhou University,Institute of Medical and Pharmaceutical Sciences
[3] Zhengzhou University,Clinical Research Division
[4] Berry Oncology Corporation,undefined
来源
Journal of Translational Medicine | / 19卷
关键词
fusion; Complex rearrangements; Non-small cell lung cancer; Next-generation sequencing; Targeted therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 281 条
[11]  
Jiang GY(2019)Tracing oncogene rearrangements in the mutational history of lung adenocarcinoma Cell 177 1842-1857
[12]  
Le LP(2019)Wake up and smell the fusions: single-modality molecular testing misses drivers Clin Cancer Res 25 4586-4588
[13]  
Gowen K(2018)Comparison of molecular testing modalities for detection of ROS1 rearrangements in a cohort of positive patient samples J Thorac Oncol 13 1474-1482
[14]  
Kwak EL(2020)Intergenic breakpoints identified by DNA sequencing confound targetable kinase fusion detection in NSCLC J Thorac Oncol 15 1223-1231
[15]  
Bang YJ(2009)Fast and accurate short read alignment with Burrows-Wheeler transform Bioinformatics 25 1754-1760
[16]  
Camidge DR(2009)Genome project data processing S: the sequence alignment/map format and SAMtools Bioinformatics 25 2078-2079
[17]  
Shaw AT(2010)The genome analysis toolkit: a mapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 1297-1303
[18]  
Solomon B(2011)FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution Bioinformatics 27 1922-1928
[19]  
Maki RG(2013)Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma Ann Oncol 24 2589-2593
[20]  
Ou SH(2012)Why technical aspects rather than biology explain cellular heterogeneity in ALK-positive non-small cell lung cancer J Thorac Dis 4 240-241